EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C19H21NO2.HBr |
| Net Charge | 0 |
| Average Mass | 376.294 |
| Monoisotopic Mass | 375.08339 |
| SMILES | Br.C=CCN1CCc2cc(O)c(O)cc2C(c2ccccc2)C1 |
| InChI | InChI=1S/C19H21NO2.BrH/c1-2-9-20-10-8-15-11-18(21)19(22)12-16(15)17(13-20)14-6-4-3-5-7-14;/h2-7,11-12,17,21-22H,1,8-10,13H2;1H |
| InChIKey | JWQRAXTWDYUBFI-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Role: | dopamine agonist A drug that binds to and activates dopamine receptors. |
| Applications: | prodrug A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. dopamine agonist A drug that binds to and activates dopamine receptors. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide (CHEBI:63978) has part N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepinium-7,8-diol(1+) (CHEBI:63987) |
| N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide (CHEBI:63978) has role dopamine agonist (CHEBI:51065) |
| N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide (CHEBI:63978) has role prodrug (CHEBI:50266) |
| N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide (CHEBI:63978) is a hydrobromide (CHEBI:48367) |
| IUPAC Name |
|---|
| 1-phenyl-3-(prop-2-en-1-yl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol hydrobromide |
| Synonyms | Source |
|---|---|
| SKF 77434 hydrobromide | ChEBI |
| 3-allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol hydrobromide | IUPAC |
| N-allyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrobromide | ChEBI |
| 3-allyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepinium bromide | IUPAC |
| Registry Numbers | Sources |
|---|---|
| Reaxys:8658505 | Reaxys |